Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| BRD4-targeting PROTAC as a unique tool to study biomolecular condensates. | Cell Discov | 2023 | 37156794 | PubTator, text mining | PubMed |
| Targeted protein degradation bypassing cereblon and von Hippel-Lindau. | Innovation (Camb) | 2023 | 37151909 | PubTator, text mining | PubMed |
| Fragment Linker Prediction Using the Deep Encoder-Decoder Network for PROTACs Drug Design. | J Chem Inf Model | 2023 | 37150933 | PubTator, text mining | PubMed |
| Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. | MedComm (2020) | 2023 | 37143582 | PubTator, text mining | PubMed |
| Identification of SPRYD4 as a tumour suppressor predicts prognosis and correlates with immune infiltration in cholangiocarcinoma. | BMC Cancer | 2023 | 37142983 | PubTator, text mining | PubMed |
| Targeting bromodomain-containing proteins: research advances of drug discovery. | Mol Biomed | 2023 | 37142850 | PubTator, text mining | PubMed |
| Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions. | Am J Clin Dermatol | 2023 | 37140884 | PubTator, text mining | PubMed |
| Development of versatile solid-phase methods for syntheses of PROTACs with diverse E3 ligands. | Bioorg Med Chem | 2023 | 37126968 | PubTator, text mining | PubMed |
| Formation of C(sp2)-C(sp3) Bonds Instead of Amide C-N Bonds from Carboxylic Acid and Amine Substrate Pools by Decarbonylative Cross-Electrophile Coupling. | J Am Chem Soc | 2023 | 37126234 | PubTator, text mining | PubMed |
| Autonomous Synthesis of Functional, Permanently Phosphorylated Proteins for Defining the Interactome of Monomeric 14-3-3ζ. | ACS Cent Sci | 2023 | 37122473 | PubTator, text mining | PubMed |
| An integrated modelling approach for targeted degradation: insights on optimization, data requirements and PKPD predictions from semi- or fully-mechanistic models and exact steady state solutions. | J Pharmacokinet Pharmacodyn | 2023 | 37120680 | PubTator, text mining | PubMed |
| Targeting Myc-driven stress addiction in colorectal cancer. | Drug Resist Updat | 2023 | 37119690 | PubTator, text mining | PubMed |
| Discovery of novel BTK PROTACs with improved metabolic stability via linker rigidification strategy. | Eur J Med Chem | 2023 | 37119666 | PubTator, text mining | PubMed |
| Novel duplication of the cell adhesion molecule L1-like gene in an individual with cognitive impairment, tall stature, and obesity: A case report. | Front Neurol | 2023 | 37114233 | PubTator, text mining | PubMed |
| Novel Developments to Enable Treatment of CNS Diseases with Targeted Drug Delivery. | Pharmaceutics | 2023 | 37111587 | PubTator, text mining | PubMed |
| Potential Use of Thalidomide in Glioblastoma Treatment: An Updated Brief Overview. | Metabolites | 2023 | 37110201 | PubTator, text mining | PubMed |
| Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery. | ACS Bio Med Chem Au | 2023 | 37101607 | PubTator, text mining | PubMed |
| Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera. | J Biomed Sci | 2023 | 37101169 | PubTator, text mining | PubMed |
| Chemical and Biological Strategies for Profiling Protein-Protein Interactions in Living Cells. | Chem Asian J | 2023 | 37089007 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=37